Pedro Landete
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pedro Landete as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:29 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05121740 · Extension Study in a Cohort of Adult Patients With COVID-19 InfectionPharmaMar · completed · COVID-19 Infection · principal investigator
- N/ANCT04691479 · Adherence and Quality of Life of CPAP for Obstructive Sleep ApneaAir Liquide Healthcare Spain · completed · Sleep Apnea, Obstructive · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:29 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.J Clin Invest · 2020158 citationsRCR 6.0
- Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.Life Sci Alliance · 202239 citationsRCR 2.5
- A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19.Clin Infect Dis · 202412 citationsRCR 2.4
- 5 citationsRCR 0.6